TY  - GEN
AU  - Bourgne,Céline
AU  - Janel,Alexandre
AU  - Berger,Juliette
AU  - Rapatel,Chantal
AU  - Tournilhac,Olivier
AU  - Hermet,Eric
AU  - Guerci,Agnès
AU  - Lioret,Frédérique
AU  - Briançon,Aurélie
AU  - Bamdad,Mahchid
AU  - Boiret-Dupré,Nathalie
AU  - Berger,Marc G
TI  - Phosphorylation of spleen tyrosine kinase at tyrosine 348 (pSyk³⁴⁸) may be a marker of advanced phase of Chronic Myeloid Leukemia (CML)
SN  - 1873-5835
PY  - 2015///0507
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - Blast Crisis
KW  - Child
KW  - Chronic Disease
KW  - Dasatinib
KW  - Disease Progression
KW  - Female
KW  - Flow Cytometry
KW  - Follow-Up Studies
KW  - Humans
KW  - Intracellular Signaling Peptides and Proteins
KW  - genetics
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Oxazines
KW  - pharmacology
KW  - Phosphorylation
KW  - Prognosis
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - Pyridines
KW  - Pyrimidines
KW  - RNA, Messenger
KW  - Real-Time Polymerase Chain Reaction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Survival Rate
KW  - Syk Kinase
KW  - Thiazoles
KW  - Tumor Cells, Cultured
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.leukres.2014.11.014
ER  -